References
- Feder RJ, Michell MJ. Hyperfunctional, hyperacidic, and intubation granulomas. Arch Otolaryngol 1984;110:582–4.
- Karkos PD, George M, Van Der Veen J, Atkinson H, Dwivedi RC, Kim D, et al. Vocal process granulomas: a systematic review of treatment. Ann Otol Rhinol Laryngol 2014;123:314–20.
- Havas TE, Priestley J, Lowinger DSG. A management strategy for vocal process granulomas. Laryngoscope 1999;109:301–6.
- Ylitalo R, Lindestad PA. A retrospective study of contact granuloma. Laryngoscope 1999;109:433–6.
- Kawasaki Y, Fukuda H, Sako T, Sasaki S, Sakaguchi R, Siotani A, et al. Clinical studies of becrobethasone dipropionate inhaler (Aldecin®) on granulomas of the larynx. Jpn Bronchoesophagol Soc 1994;45:244–8.
- Roh HJ, Goh EK, Chon KM, Wang SG. Topical inhalant steroid (budesonide, Pulmicort nasal) therapy in intubation granuloma. J Laryngol Otol 1999;113:612–7.
- Emami AJ, Morrison M, Rammage L, Bosch D. Treatment of laryngeal contact ulcers and granulomas: a 12-year retrospective analysis. J Voice 1999;13:612–7.
- Wani MK, Woodson GE. Laryngeal contact granuloma. Laryngoscope 1999;109:1589–93.
- Hillel AT, Lin LM, Samlan R, Starmer H, Leahy K, Fint PW. Inhaled triamcinolone with proton pump inhibitor for treatment of vocal process granulomas: a series of 67 granulomas. Ann Otol Rhinol Laryngol 2010;119:325–30.
- Horiguchi S, Suzuki M, Takagi H, Yamanishi T, Nakamura K. Clinical course of laryngeal granuloma without surgical treatment. Diagn Ther Endosc 2001;7:129–33.
- Wang C-P, Ko J-Y, Wang Y-H, Hu Y-L, Hsiao T-Y. Vocal process granuloma – A result of long-term observation in 53 patients. Oral Oncology 2009;45:821–5.
- Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111:1313–7.
- Pontes PA, De Biase NG, Gadelha EC. Clinical evolution of laryngeal granulomas: treatment and prognosis. Laryngoscope 1999;109:289–94.
- Lee SW, Hong HJ, Choi SH, Sun DI, Park YH, Lee BJ, et al. Comparison of treatment modalities for contact granuloma: a nationwide multicenter study. Laryngoscope 2014;124:1187–91.
- Pontes P, De Biase N, Kyrillos L, Pontes A. Importance of glottic configuration in the development of posterior laryngeal granuloma. Ann Otol Rhinol Laryngol 2001;110:765–9.
- Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000;123:385–8.
- Hanson DG, Kamel PL, Kahrilas PJ. Outcomes of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995;104:550–5.
- Kinoshita Y, Ishihara S. Causes of and therapeutic approaches for, proton pomp inhibitor-resistant gastroesophageal reflux disease in Asia. Therap Adv Gastroenterol 2008;1:191.
- Hicks DM, Ours TM, Abelson TI, Vaezi MF, Richter JE. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002;16:564–79.
- Rennard SI, Togo S, Holz O. Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema. Proc Am Thorac Soc 2006;3:703–8.
- Nakamura Y, Romberger DJ, Tate L, Ertl RF, Kawamoto M, Adachi Y, et al. Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. Am J Respir Crit Care Med 1995;151:1497–503.